An innovative pharmaceutical company JSC “Valenta Pharm” from day one has been engaged in the development, manufacture and market launch of high-quality Prescription medicinal products and Over-the counter medicines.

JSC “Valenta Pharm” is pursuing its mission to create high quality innovative medicinal products that contribute to the prevention and treatment of neuropsychiatry, gastroenterology disorders, and cold-related diseases, and beyond. The Company is committed to providing doctors and patients with cutting-edge and sophisticated tools to address medical and healthcare needs, hence improving the welfare of people.

The Product Portfolio of the Company is represented by well-known brands, such as Ingavirin®, Grammidin®, Sinusephrine® , Olyfrin ®, Trimedat®, Rehydron®, Duonica®, Teraligen®, Phenazepam®, Kinezia®, Phenotropil®, etc.  Nearly 100 Million packs of Finished products per annum are currently manufactured by the Company, successfully catering for the demands  of socially significant diseases.

Valenta’s Research & Production Facility (R&P Facility) is located in Shchyolkovo, Moscow Region. The total area of the Research & Production Facility covers 19,000 square meters. The target output capacity is 2 billion tablets and capsules per year. This R&P Facility is a vivid demonstration of a consolidated and uncompromising approach to implementation and compliance with all GMP guidelines, requirements and standards.

The Company has representations in the Republic of Belarus, the Kyrgyz Republic, the Republic of Azerbaijan, Armenia, the Republic of Kazakhstan and the Republic of Uzbekistan.